Purchases and Sales Made in Q2 2020 in Tcr2 Therapeutics Inc. (TCRR)
This table provides information about the institutional ownership of Tcr2 Therapeutics Inc. (TCRR) during Q2 2020. The information is specifically focused on institutions that hold shares of TCR2 THERAPEUTICS INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2020
Q2 2020
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-30.6KClosed |
$199K - $516K
|
0
$0
|
|
|
Aug 14, 2020
Q2 2020
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-31.2K- 43.84% |
$203K - $525K
|
39.9K
$0
|
|
|
Aug 14, 2020
Q2 2020
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-32.6K- 41.38% |
$212K - $549K
|
46.2K
$0
|
|
|
Aug 14, 2020
Q2 2020
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-50K- 12.5% |
$326K - $843K
|
350K
$0
|